Biotech

All Articles

Novo inks $600M NanoVation deal to research genetic medications ex-liver

.Novo Nordisk is continuing its own push in to hereditary medications, accepting to pay NanoVation T...

Innovent links cytokine to colon cancer cells actions

.Innovent Biologics has actually made the situation that its own checkpoint inhibitor-cytokine blend...

Merck, Daiichi ADC strikes goal in phase 3 bronchi cancer cells research study

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows artificial intelligence focus with collab to decide on cancer targets

.Five months after Rakovina Therapies pivoted towards artificial intelligence, the cancer-focused bi...

Ascendis' dwarfism medication hits in stage 3, intimidates BioMarin

.Ascendis Pharma has emerged as a possible threat to BioMarin's Voxzogo, reporting stage 3 developme...

Despite ph. 3 miss, Alkeus views pathway ahead of time for eye disease property

.Though Alkeus Pharmaceuticals' oral eye condition resource stopped working to substantially lessen ...

Kairos goes public along with $6M IPO to money tests of cancer medicine

.With a triad of biotechs hitting the Nasdaq on Friday, it was very easy to miss a smaller-scale pub...

Vaccine as well as Keytruda combo helpful in squamous cell cancer

.Immune system checkpoint inhibitors are actually the superheroes of cancer cells treatment. Medicin...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, firings as we...

Regeneron's Opdualag opponent shows 57% response price

.Regeneron is actually back with long-term consequence for its LAG-3 inhibitor as well as PD-1 preve...